Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (37)
Shuo Wu, Shipei Qiu, Wei Chen, Liucheng Ding & Lejun Wu. (2022) Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer. Disease Markers 2022, pages 1-14.
Crossref
Crossref
Zongtai Zheng, Yadong Guo, Xiongsheng Huang, Ji Liu, Ruiliang Wang, Xiaofu Qiu & Shenghua Liu. (2022) CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer. Cancers 14:19, pages 4866.
Crossref
Crossref
J. Gaudelus. (2022) Actualités du BCG. La Presse Médicale Formation 3:4, pages 305-312.
Crossref
Crossref
Xiaoyi Hu, Weilin Zhou, Ruyu Pi, Xia Zhao & Wei Wang. (2022) Genetically modified cancer vaccines: Current status and future prospects. Medicinal Research Reviews 42:4, pages 1492-1517.
Crossref
Crossref
Priyanka Sekar, Raashmi Ravitchandirane, Sofia Khanam, Nethaji Muniraj & Ananda Vayaravel Cassinadane. (2022) Novel molecules as the emerging trends in cancer treatment: an update. Medical Oncology 39:2.
Crossref
Crossref
Xiaoshuai Wang, Jingwei Yu, Jinbao Chen, Yingdong Hou, Zefeng Du, Haoyang Huang, Siqi Tang, Yueyin Han, Changhai Ding & Zhicheng Xue. (2021)
Copy number variation analysis of m
6
A regulators identified METTL3 as a prognostic and immune‐related biomarker in bladder cancer
. Cancer Medicine 10:21, pages 7804-7815.
Crossref
Crossref
Esma Mouhoub, Pilar Domenech, Momar Ndao & Michael B. Reed. (2021) The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview. Frontiers in Microbiology 12.
Crossref
Crossref
Ajay Gupta, Sumit Sural, Ayush Gupta, Shashank Rousa, Bidhan Chandra Koner, Anju Bhalotra & Rohit Chawla. (2021) Positive QuantiFERON test and the severity of COVID-19 disease: A prospective study. Indian Journal of Tuberculosis 68:4, pages 474-480.
Crossref
Crossref
Zouina Sarfraz, Azza Sarfraz, Krunal Pandav, Sarabjot Singh Makkar, Saman Hasan Siddiqui, Gaurav Patel, Tania Platero-Portillo, Bishnu Mohan Singh, Mohamed Iburahim Haja Maideen, Deepika Sarvepalli, Muzna Sarfraz, Jose Cardona-Guzman, Marcos A. Sanchez-Gonzalez & Ivan Cherrez-Ojeda. (2021) Variances in BCG protection against COVID-19 mortality: A global assessment. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 24, pages 100249.
Crossref
Crossref
Zhongyuan Guo, Luke J. Kubiatowicz, Ronnie H. Fang & Liangfang Zhang. (2021) Nanotoxoids: Biomimetic Nanoparticle Vaccines against Infections. Advanced Therapeutics 4:8, pages 2100072.
Crossref
Crossref
Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossainpour, Amirhoushang Alvandi, Jale Moradi & Ramin Abiri. (2021) An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. International Immunopharmacology 96, pages 107763.
Crossref
Crossref
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjörn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, Ihsan Gursel & Siobhán McClean. (2021) Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 13:4, pages 501.
Crossref
Crossref
Kuan-Wei Shih, Wei-Chieh Chen, Ching-Hsin Chang, Ting-En Tai, Jeng-Cheng Wu, Andy C. Huang & Ming-Che Liu. (2021) Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions. Aging and disease 12:3, pages 868.
Crossref
Crossref
Abu Salim Mustafa. (2020) BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers. Vaccines 8:4, pages 736.
Crossref
Crossref
Aliae A. R. Mohamed Hussein, Marwa Rashad Salem, Samar Salman, A F Abdulrahim, Nasrallah A. Al Massry, Mahmoud Saad, Nesrine Ben Hadj Dahman & Ahmed Negida. (2020) Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?. The Egyptian Journal of Bronchology 14:1.
Crossref
Crossref
Pramod Kumar Gupta. (2020) New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?. Cellular Immunology 356, pages 104187.
Crossref
Crossref
Francois Henri Jacques & Erik Apedaile. (2020) Immunopathogenesis of COVID-19: Summary and Possible Interventions. Frontiers in Immunology 11.
Crossref
Crossref
N. I. Nadolinskaia, D. S. Karpov & A. V. Goncharenko. (2020) Vaccines Against Tuberculosis: Problems and Prospects (Review). Applied Biochemistry and Microbiology 56:5, pages 497-504.
Crossref
Crossref
Simon G. Kimuda, Irene Andia-Biraro, Ismail Sebina, Moses Egesa, Angela Nalwoga, Steven G. Smith, Bernard S. Bagaya, Jonathan Levin, Alison M. Elliott, John G. Raynes & Stephen Cose. (2020) Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens. Scientific Reports 10:1.
Crossref
Crossref
Ying Zhou, Peter J. Little, Liam Downey, Rizwana Afroz, Yuao Wu, Hang T. Ta, Suowen Xu & Danielle Kamato. (2020) The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease. ACS Pharmacology & Translational Science 3:3, pages 457-471.
Crossref
Crossref
Coad Thomas Dow. (2020) Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases. Microorganisms 8:2, pages 212.
Crossref
Crossref
Steven C. Derrick. 2020. Mucosal Vaccines. Mucosal Vaccines
401
417
.
Katlyn Borgers, Jheng-Yang Ou, Po-Xing Zheng, Petra Tiels, Annelies Van Hecke, Evelyn Plets, Gitte Michielsen, Nele Festjens, Nico Callewaert & Yao-Cheng Lin. (2019) Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine. BMC Genomics 20:1.
Crossref
Crossref
Martha Lucia Ruiz Benitez, Camila Bonnemann Bender, Thaís Larré Oliveira, Kyle M. Schachtschneider, Tiago Collares & Fabiana Kömmling Seixas. (2019) Mycobacterium bovis BCG in metastatic melanoma therapy. Applied Microbiology and Biotechnology 103:19, pages 7903-7916.
Crossref
Crossref
Dongkui Song, Thomas Powles, Lei Shi, Lirong Zhang, Molly A Ingersoll & Yong‐Jie Lu. (2019) Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches. The Journal of Pathology 249:2, pages 151-165.
Crossref
Crossref
Sanja Nabergoj, Irena Mlinarič‐Raščan & Žiga Jakopin. (2018) Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy. Medicinal Research Reviews 39:5, pages 1447-1484.
Crossref
Crossref
Sonia Qureshi, Khalil Ahmad, Paras Fatima, Rabia M. Hassan, Farheen Sherali, Naureen Lalani, Fyezah Jehan, Syed Asad Ali & Farah Naz Qamar. (2019) Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series. PLOS ONE 14:7, pages e0219324.
Crossref
Crossref
Sergio Rius-Rocabert, Francisco Llinares Pinel, Maria Jose Pozuelo, Antonia García & Estanislao Nistal-Villan. (2019) Oncolytic bacteria: past, present and future. FEMS Microbiology Letters 366:12.
Crossref
Crossref
Sumit Joshi, Narendra Kumar Yadav, Keerti Rawat, Vikash Kumar, Rafat Ali, Amogh Anant Sahasrabuddhe, Mohammad Imran Siddiqi, Wahajul Haq, Shyam Sundar & Anuradha Dube. (2019) Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani. Frontiers in Immunology 10.
Crossref
Crossref
Sudeep Kumar. 2019. Pharmaceuticals from Microbes. Pharmaceuticals from Microbes
39
73
.
M. Unda-Urzaiz, J.M. Cozar-Olmos, B. Miñana-Lopez, J. Camarero-Jimenez, X. Brugarolas-Rossello, C. Zubiaur-Libano, M.J. Ribal-Caparros, A.J. Suarez-Charneco, V. Rodriguez-Tesedo, V. Chantada-Abal, C. Gonzalez-Ruiz-de-Leon, C. Carrillo-George, J. Carballido-Rodriguez & F. Villacampa-Auba. (2018) Safety and efficacy of various strains of bacille Calmette–Guérin in the treatment of bladder tumors in standard clinical practice. Actas Urológicas Españolas (English Edition) 42:4, pages 238-248.
Crossref
Crossref
M. Unda-Urzaiz, J.M. Cozar-Olmos, B. Miñana-Lopez, J. Camarero-Jimenez, X. Brugarolas-Rossello, C. Zubiaur-Libano, M.J. Ribal-Caparros, A.J. Suarez-Charneco, V. Rodriguez-Tesedo, V. Chantada-Abal, C. Ruiz-de-Leon, C. Carrillo-George, J. Carballido-Rodriguez & F. Villacampa-Auba. (2018) Eficacia y seguridad de distintas cepas de BCG en el tratamiento del tumor vesical en práctica clínica habitual. Actas Urológicas Españolas 42:4, pages 238-248.
Crossref
Crossref
Natalie E. Nieuwenhuizen & Stefan H. E. Kaufmann. (2018) Next-Generation Vaccines Based on Bacille Calmette–Guérin. Frontiers in Immunology 9.
Crossref
Crossref
Natalie E. Nieuwenhuizen, Prasad S. Kulkarni, Umesh Shaligram, Mark F. Cotton, Cyrill A. Rentsch, Bernd Eisele, Leander Grode & Stefan H. E. Kaufmann. (2017) The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing. Frontiers in Immunology 8.
Crossref
Crossref
Panos Lehouritis, Glenn Hogan & Mark Tangney. (2017) Designer bacteria as intratumoural enzyme biofactories. Advanced Drug Delivery Reviews 118, pages 8-23.
Crossref
Crossref
M Gengenbacher, NE Nieuwenhuizen & SHE Kaufmann. (2017) BCG — old workhorse, new skills. Current Opinion in Immunology 47, pages 8-16.
Crossref
Crossref
Tsungai Ivai Jongwe, Ros Chapman, Nicola Douglass, Shivan Chetty, Gerald Chege & Anna-Lise Williamson. (2016) HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice. PLOS ONE 11:7, pages e0159141.
Crossref
Crossref